Figure 3From: Impact of innate immunity in a subset of children with autism spectrum disorders: a case control studyHigher IL-23 production with a TLR4 agonist in the ASD test group without LPS pre-treatment. IL-23 production with a TLR4 agonist was lower in the ASD test group than in the ASD and normal case controls.Back to article page